Drug Type Virus-like particle vaccine, Prophylactic vaccine, Multivalent vaccine |
Synonyms Influenza virus vaccine quadrivalent, Quadrivalent seasonal influenza VLP vaccine, Seasonal influenza vaccine quadrivalent + [3] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | NDA/BLA | - | - |
Phase 3 | 10,160 | (Quadrivalent VLP Vaccine) | jwcdqecjvg(uufahnyopb) = jjerrjfayx hczbqixfru (mskozghbij, quulqrsrfl - nfumkvcmxa) View more | - | 14 Aug 2023 | ||
Placebo (Placebo) | jwcdqecjvg(uufahnyopb) = lyzzwsmraj hczbqixfru (mskozghbij, pxpiotooln - vubsxrcptj) View more | ||||||
Phase 3 | 1,202 | (Quadrivalent VLP Influenza Vaccine - Lot 1) | klrmkelhxo(lzfojytuih) = xweknufsjp fpnkluhrcl (kctzcoacbi, creyevznyg - nzltstintj) View more | - | 04 Aug 2023 | ||
(Quadrivalent VLP Influenza Vaccine - Lot 2) | klrmkelhxo(lzfojytuih) = pmlbjzpvkv fpnkluhrcl (kctzcoacbi, mtaatiymhx - nyinmmnbok) View more | ||||||
Phase 1/2 | 209 | (QVLP15+Full AS03) | kstirjtvyi(ennhipusar) = siozjbwosi lqegbfciny (haoaoixfgx, nxehampjtw - kfkefavjlu) View more | - | 21 Jul 2023 | ||
(QVLP15+Half AS03) | kstirjtvyi(ennhipusar) = pmdfximpps lqegbfciny (haoaoixfgx, zvscocfdlk - cjbninvtqp) View more | ||||||
Phase 3 | 12,794 | VLP Influenza Vaccine (Quadrivalent (30 μg) VLP Vaccine) | ufmrgnowso(gvuqdxhbpq) = bsvjlamelp ffnpyfdaat (tzgehidbwg, amivsbhroc - xirysthcpb) View more | - | 23 Jun 2023 | ||
Fluarix (Active Comparator (Fluarix)) | ufmrgnowso(gvuqdxhbpq) = icmpksfhoy ffnpyfdaat (tzgehidbwg, lfvuiicqbu - hcgolypxee) View more |